SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-21-000224
Filing Date
2021-03-08
Accepted
2021-03-08 20:38:18
Documents
1
Period of Report
2021-03-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 10019
  Complete submission text file 0001192482-21-000224.txt   11510
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY, SUITE 150 MALVERN PA 19355
Business Address
Potti Manish (Reporting) CIK: 0001797537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36751 | Film No.: 21723748